Zacks Investment Research
28 Oct 2026, 16:50 UTC · 1h ago
Liquidia Gears Up to Report Q3 Earnings: What Can Investors Expect?
Impact · against what's priced in
The legal settlement with United Therapeutics creates a net negative for Liquidia by introducing significant cash outflows and a lost drug indication, offsetting the positive revenue beat. United Therapeutics benefits from the resolution of multiple disputes and the receipt of these settlement payments.
- LQDA−0.50
Challenges what's priced in
- The price assumes
The worst-case scenario from the '327 trial





